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Abstract
BACKGROUND: Chronic kidney disease is a condition of chronic kidney damage with abnormal structure and 
function of the kidneys that lasts more than 3 months, accompanied or not by a decrease in glomerular filtration rate. 
Organic kidney disease leaves accumulated organic waste that cannot be removed by the kidneys. Furthermore, 
several biochemical and metabolic mechanisms such as chronic inflammation and oxidative stress can cause 
executive disorders.
AIM: The aim of the study was to find out an increased risk of impaired cognitive function in patients with chronic 
kidney disease with a low glomerular filtration rate in Sanglah Hospital.
METHOD: This study uses a retrospective case–control analytic observational study design. We included all patients 
with chronic kidney disease in Sanglah Hospital in December 2017–January 2018. This study involved 46 subjects 
with chronic kidney disease who met eligibility criteria, classified as a case group with cognitive impairment and a 
control group without cognitive impairment.
RESULTS: Each decrease in glomerular filtration rate < 30 ml/min/173 m2 in patients with chronic renal failure 
correlates with an increased incidence of cognitive impairment of around 15–25%. The risk of chronic kidney disease 
patients with glomerular filtration rate < 30 ml/min/1.73 m2 decreased cognitive function 13 times compared to 
subjects with glomerular filtration rate > 30 ml/min/ 1.73 m2.
CONCLUSION: Low glomerular filtration rate correlate with increased risk of cognitive impairment.
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Introduction
Chronic kidney disease is chronic damage to 
kidney due to abnormalities in both structure and function 
of the kidney with or without a decrease in glomerular 
filtration rate that occurs more than 3 months. Disorders 
in the field of neurology such as cognitive impairment, 
disequilibrium syndrome, or uremic encephalopathy 
occur in chronic kidney disorders with a low glomerular 
filtration rate of < 50%.
Cognition is a process of being able to 
receive sensory input, remember an event, make 
generalizations, give analogies, explain, and 
communicate. Cognitive disorders are disturbances 
in rational thought processes including, interruptions 
in the process of receiving information, processing, 
storing, and remembering until releasing that 
information.
Arcienegas et al. (2013) divide cognitive into 
basic and complex. Basic cognitive consists of arousal, 
attention, memory, praxis, and recognition while 
cognitive complex consists of executive functions, 
social intelligence, and motivation [1].
Impaired cognitive function in chronic 
kidney disease is often overlooked and not observed 
by clinicians. Impairment of cognitive function 
here is caused by metabolic and biochemical 
mechanisms in the central nervous system in the 
form of oxidative stress, chronic inflammatory 
reactions, anemia, hyperhomocysteinemia, vascular 
problems, endothelial dysfunction, as well as uremic 
toxins.[2], [3] The previous studies have reported that 
patients with chronic kidney disease have twice the 
risk of experiencing cognitive impairment compared 
to healthy people and 4 times more often experience 
cognitive impairment when the glomerular filtration 
rate decreases to < 30 ml/min/1.73 m2. Each reduction 
in glomerular filtration rate of 10 ml/min/173 m2 in 
patients with chronic renal failure correlates with 
an increase in the incidence of impaired cognitive 
function around 15–25% and this cognitive problem 
can occur earlier 3.6–7 years [4]. Executive function 
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is one of the domains of cognitive function that is 
quite common. The executive function is a cognitive 
function with a complex process of initiating 
responses, adjusting behavior, knowing mistakes, 
forming motor movements, and making a decision. A 
meta-analysis study reported a significant relationship 
between increased risk of cognitive impairment in 
patients with chronic kidney disease, especially 
mild and moderate degrees and glomerular filtration 
rates of 45–60 ml/min/1.73 m2 [2]. Each decrease in 
glomerular filtration rate <30 ml/min/1.73 m2 in patients 
with chronic renal failure correlates with an increased 
incidence of cognitive impairment of around 15–25%.
Methods
This study is an observational analytic study 
with a case–control design to determine whether the 
low glomerular filtration rate increases the risk of 
cognitive impairment in patients with chronic kidney 
disease, taking place in Neurology and Internal 
Medicine Outpatient Clinic at Sanglah General Hospital 
in December 2017–January 2018. Based on the previous 
studies, we implement the cutoff of low glomerular 
filtration rate as < 30 ml/min/1.73 m2. The inclusion 
criteria for case group were as follows: (1) Patient with 
chronic kidney disease based on glomerular filtration 
rate < 100 ml/min/1.73 m2 or ≥ 15 ml/min/1.73 m2, (2) 
chronic kidney disease with cognitive impairment, and 
(3) 40–70 years old. Control group inclusion criteria 
are the same with case group but they should not have 
any cognitive impairment. Exclusion criteria for both 
case and control group: (1) Hemoglobin <6 mg/dL, 
(2) history of liver disease, critical illness, malignancy, 
and (3) immunity disorder such as SLE, AIDS, or other 
disease that can affect the cognitive function.
Impaired cognitive function was assessed 
with an MoCA-Ina (Montreal Cognitive Assessment-
Indonesian) instrument. The total MoCA-Ina value was 
30 with a cutoff of < 26 indicating impaired cognitive 
function. Adjustments to the MoCA-Ina for low levels of 
education must add 2 points to the total value for 4–9 
years of formal education, and 1 point for 10–12 years 
of formal education.
The data that have been obtained are 
processed either using Statistical Product and Service 
Solution (SPSS) program version 20.0. Data analysis 
is carried out in two stages, descriptive, and analytic 
statistical stages. Descriptive statistics are used to see 
an overview of the basic characteristics of research 
subjects. The statistic analysis was performed by Chi-
Square test. The level of significance was expressed as 
p < 0.05 with a 95% confidence interval.
Results
This study involved 46 subjects with chronic 
kidney disease who met the eligibility criteria, classified 
as a group of cases with cognitive impairment and control 
groups, without cognitive impairment. Characteristics of 
research subjects are presented in Table 1.
Table 1: Characteristics of research subjects
Variables Case MoCA-Ina < 26 Control MoCA-Ina >26 p-value
n (%) n (%)
Gender
Males 7 (30.4%) 13 (56.5%) 0.074
Females 16 (69.6%) 10 (43.5%)
Age
<60 years 18 (78.3%) 20 (87%) 0.437
>60 years 5 (21.7%) 3 (13%)
Education
<12 years 18 (78.3%) 7 (30.4%) 0.001
>12 years 5 (21.7%) 16 (69.6%)
Occupation
Informal
Formal
17 (73.9%)
6 (26.1%)
9 (39.1%)
14 (60.9%)
0.017
*MoCA-Ina: Montreal Cognitive Assessment-Indonesian.
In Table 1, the case group with cognitive 
impairment found seven male subjects (30.4%) and 16 
female subjects (69.6%). In the control group without 
cognitive impairment, there were 13 male subjects 
(56.5%) and ten female subjects (43.5%), with p = 0.074 
which means that there were no significant differences 
in the sex variables.
There are 18 people (78.3%; <60 years) and 
five elderly (21.7%; ≥ 60 years) in the case group. In the 
control group, there are 20 people (87%; < 60 years) 
and three elderly (13%; ≥ 60 years), with p = 0.437, 
which means there were no significant differences in 
the age variable in both case and control groups.
In this study, the case group found the education 
<12 years by 18 people (78.3%) and education >12 
years by five people (21.7%). In the control group, it 
was found that the education <12 years was seven 
people (30.4%), while education >12 years was 16 
people (69.6%), with p = 0.001 which means that there 
were significant differences in the education variable.
In the occupational variable, the case group 
found subjects with 17 informal occupations (73.9%) 
and six with formal occupations (26.1%). In the 
control group, there were subjects with nine informal 
occupations (39.1%) and 14 with formal occupations 
(22.9%), with p = 0.017 which means that there were 
significant differences in the types of occupation 
variables.
The correlation between glomerular filtration 
rate and cognitive function using MoCA-Ina is described 
in Table 2. Seventeen patient with impaired cognitive 
Table 2: The correlation between glomerular filtration rate and 
cognitive function using MoCA-Ina
Variable Cognitive impairment
MOCA-Ina
OR
(95% CI)
p-value
Yes n (%) No n (%)
Glomerular filtration rate
(ml/min/1,73m2)
< 30 17 (73.9%) 4 (17.4%) 13,45
(3.23–55.92)
< 0.001*
> 30 6 (26.1%) 19 (82.6%)
*OR: Odds ratio, CI: Confidence interval; n: Number of subjects.
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function was found in low glomerular filtration rate patient 
< 30 ml/min/1.73 m2 (73.9%), while in the control group 
with glomerular filtration rate > 30 ml/min/1.73 m2 only 
six patient (26.1%). There is a significant difference in 
the occurrence of cognitive impairment in patients with 
chronic kidney disease with a glomerular filtration rate 
< 30 ml/min/1.73 m2 compared to patients with chronic 
kidney disease with a glomerular filtration rate > 30 ml/
min/1.73 m2 with an OR 13.45, 95% CI 3.23-55.92 and 
p < 0.001. The risk of chronic kidney disease with a 
glomerular filtration rate <30 ml/min/1.73 m2 decreased 
cognitive function is 13 times compared to subjects with 
glomerular filtration rate > 30 ml/min/1.73 m2 which is 
statistically significant.
Other factors such as anemia, high blood 
pressure, diabetes mellitus, and hemodialysis also play 
a role in causing cognitive dysfunction. The relationship 
of other factors as a cause of cognitive decline was 
analyzed using the Chi-square test and Fisher’s Exact. 
The analysis results are presented in Table 3.
Table 3: The other factors correlated to decrease cognitive 
function
Variables Cognitive impairment OR (95% CI) p-value
Yes n (%) No n (%)
Diabetes mellitus
Yes
No
6 (26.1)
17 (73.9)
5 (21.7)
18 (78.3)
1.27 (0.03–4.94) 0.5
Hypertension
Yes
No
15 (65.2)
8 (34.8)
17 (73.9)
6 (26.1)
0.66 (0.18–2.34) 0.37
Anemia
Yes
No
21 (91.3)
2 (8.7)
20 (87.0)
3 (13.0)
0.5 (0.23–10.43) 0.63
Hemodialysis
Yes
No
13 (56.5)
10 (43.5)
6 (26.1)
17(73.9)
3.683 (1.06–12.77)
0.03
*OR: odds ratio; CI: confidence interval; n: number of subjects.
Impaired cognitive function in subjects with 
diabetes mellitus was 26.1%, while in subjects without 
diabetes mellitus it was 73.9%. The relationship between 
diabetes mellitus and decreased cognitive function 
was analyzed using the Chi-square test and obtained 
OR 1.27, 95% CI 0.03–4.94, p = 0.5 which means that 
statistically there was no significant relationship between 
diabetes mellitus and cognitive function decline.
The incidence of cognitive decline in subjects 
with high blood pressure was 65.2% and in subjects 
who were not with high blood pressure were 34.8%. 
The relationship between high blood pressure and 
decreased cognitive function was analyzed using 
the Chi-square test and OR 0.66, 95% CI 0.18–2.34, 
p = 0.37 which means that statistically there was no 
significant relationship between blood pressure and 
cognitive function decline.
The decrease in cognitive function in subjects 
with anemia was 91.3% and in subjects without anemia 
it was 8.7%. The relationship between anemia and 
decreased cognitive function was analyzed using 
Fisher’s exact test and obtained OR 0.5, 95% CI 0.23–
10.47, p = 0.63, which means that statistically there 
was no significant relationship between anemia and 
cognitive decline.
The incidence of cognitive decline in subjects 
with hemodialysis was 56.5% and in subjects without 
hemodialysis was 43.5%. The relationship between 
hemodialysis and cognitive decline was analyzed 
using the Chi-square test and obtained OR 3.68, 95% 
CI 1.06–12.77, p = 0.03 which means that statistically 
there is a significant relationship between hemodialysis 
and decreased cognitive function.
Discussion
This study showed that the risk of experiencing 
cognitive impairment in patients with chronic kidney 
disease in subjects with a glomerular filtration rate 
< 30 ml/min/1.73 m2 is 13 times compared to subjects 
with glomerular filtration rate values > 30 ml/min/1.73 m2 
where this result is statistically significant. The same 
thing is in line with research conducted by Bronas et al. 
(2017), the risk increases to 4 times when the glomerular 
filtration rate decreases to < 30 ml/min/1.73 m2 [4]. 
Patients with chronic kidney disease can experience 
impaired cognitive function more quickly 3.6–7 years 
compared to normal individuals. Another study by 
Bugnicourt et al. (2013) found that patients with 
chronic kidney disease with glomerular filtration rate 
< 30 ml/min/1.73 m2 are more often experience cognitive 
impairment in all domains of attention, language, 
visuospatial, memory, and function executive [5]. In 
another cross-sectional study by Buchman et al. (2009), 
kidney disease patients with low glomerular filtration 
rates experienced faster cognitive impairment [6]. It is 
said that chronic stage kidney disease is associated with 
an increased risk of dementia of about 37%. In another 
study by Kurrela et al. (2004) in 80 participants they 
obtained a prevalence of impaired cognitive function 
around 23–28% in chronic kidney disease Stage 3 to 
Stage 4 [4], [5], [7].
The kidneys and brain have similarities in 
anatomy and vasoregulatory features where it has 
low vascular resistance that can ease vascular injury. 
The prevalence of traditional vascular risk factors 
such as arterial hypertension is higher in patients with 
chronic kidney disease than in the general population. 
The presence of vascular abnormalities tends to 
cause cognitive impairment compared to Alzheimer’s 
dementia in patients with chronic kidney disease. The 
study of Helmer et al. (2011) was found that a decrease 
in kidney function by > 4 ml/min/1.73 m2 for 4 years is 
associated with a decrease in overall cognitive function 
and vascular dementia [8]. More often there are 
cognitive function disorders in the domain of executive 
function, but memory function and other domains can 
also occur [2], [5].
An increase in cognitive decline in kidney 
disease patients is related to various factors, either due 
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to metabolic disorders such as uremic, oxidative stress, 
or due to vascular endothelial dysfunction. The presence 
of these factors causes vascular dysfunction associated 
with disorders of white matter and neurodegenerative 
damage associated with uremic toxins, homocysteine, 
creatinine, and cystatin C [4], [9].
In a previous study, in 336 study subjects 
obtained low scores on cognitive screening using MMSE 
in patients with chronic kidney disease by hemodialysis. 
The existence of a low cognitive screening value is 
related to mortality rates and length of hospital stay in 
patients with chronic kidney disease [10].
Another study, namely, Kurrela, et al. (2006) 
in 16.694 research subjects with hemodialysis found 
a correlation between dialysis and dementia [11]. In 
subjects with hemodialysis with impaired cognitive 
function such as dementia, the risk of death was higher 
(RR 1.48, 95% CI 1.32–1.66). The presence of uremic 
factors is associated with cognitive impairment in patients 
with chronic kidney disease by dialysis [11], [12].
In this study, we found no significant 
relationship between high blood pressure and cognitive 
impairment. This is in contrast to research conducted 
by Iadecola et al. in 2016 in patients with high blood 
pressure, it was found that hypertension is associated 
with the occurrence of cognitive dysfunction in the long 
term [13]. In another study, by Pase et al. in 2016 in 
a cohort study it was found that aortic thickening as a 
predictor of the occurrence of both mild and dementia 
cognitive impairment in non-diabetic patients followed 
for 10 years [14]. Other study conducted by Khatri et al. 
(2009) with a cohort design on 3.029 research subjects 
with chronic kidney disease, at a glomerular filtration 
rate < 60 ml/min/1.73 m2 obtained 74% with high 
blood pressure and 86% in this group with cognitive 
impairment with p < 0.001 [15].
Various research studies have examined the 
relationship between diabetes mellitus and cognitive 
impairment. In the study of Spauwen et al. (2013) with 
a prospective cohort design for 12 years, it was found 
that individuals with diabetes mellitus had a tendency 
to experience cognitive dysfunction, especially in 
processing speed and executive function compared to 
normal individuals [16]. Roberts, et al. (2013) examined 
the relationship of diabetes with memory disorders with 
a prospective 5-year design that diabetes increased the 
risk of mild cognitive impairment with OR 1.39, 95% CI 
1.08-1.79 [17].
In contrast to the study conducted by 
MacKnight, et al. (2002) who examined the relationship 
of diabetes with Alzheimer’s and vascular cognitive 
impairment with a prospective cohort design of 5 years, 
the results showed no relationship between diabetes 
and the incidence of Alzheimer’s dementia, RR 0.87, 
95% CI 0.34–2.21 [18]. In addition, in a study conducted 
by Paraizo et al. (2015), there were also no significant 
results of cognitive impairment with high blood pressure 
in the case and control groups with a value of p = 0.06. In 
this study, the results were not meaningful because the 
number of subjects with diabetes mellitus was almost 
the same in the case and control groups. In addition, 
the effects of the duration of suffering from diabetes, as 
well as the use of diabetes drugs such as insulin were 
not analyzed in this study [19].
A positive correlation of anemia with impaired 
cognitive function was found in two recent studies 
in 2013, namely, The Health ABC Study conducted 
by Hong, et al. a study to determine the relationship 
of anemia and risk of dementia with a cohort design 
in which patient development was followed for 
11 years [20]. The results show that anemia is 
associated with an increased risk of dementia which is 
23% compared to 17%, with a risk of dementia of 1.6 
times compared to normal people. The second study, in 
a systematic review design, has the same goal states 
that there is a possible relationship between anemia 
and cognitive impairment, especially executive function, 
and if cognitive impairment has occurred because of 
anemia, anemia correction must be sought to reach the 
normal level of hemoglobin. In another study, Antunes 
et al. (2011) in 214 elderly study subjects with renal 
impairment, the results obtained were around 54.5% 
anemia research subjects with glomerular filtration rate 
<60 ml/min/1.73 m2 compared to research subjects 
with glomerular filtration rate >90 ml/min/1.73 m2 with 
p < 0.001 [21].
Studies that were negatively correlated 
among others were found in studies from Atkinson, 
et al. (2005) which stated that hemoglobin levels were 
not significantly associated with decreased cognitive 
function with OR 0.86, 95% CI 0.60–1.21 [22]. A 
study from Shah et al. (2011) also found that cognitive 
impairment could occur not only in anemia but also in 
the increased hemoglobin state (polycythemia) [23]. In 
this study, the results were not meaningful because the 
number of samples in the case and control groups was 
almost the same. In the study included in the inclusion 
criteria were patients with anemia with hemoglobin >6 
(mild-moderate anemia) while those with severe anemia 
were excluded. In addition, there was no analysis of 
the duration of anemia and a history of treatment that 
affected the quality of life of patients with anemia in 
chronic kidney disease.
Conclusion
Conclusions from the results of this study are 
an increase in the risk of impaired cognitive function by 
13 times which is statistically significant in patients with 
chronic kidney disease with a low glomerular filtration 
rate at the Sanglah General Hospital.
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